Aria Funds £54m Wildlife Gene-Editing Programme — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Aria announced 14 projects sharing an initial £30m over two years under its £54m accelerated adaptation programme, with a further £24m reserved for follow-on funding if grantees show success.
- University of Exeter researchers will use Crispr-Cas9 gene-editing on the red-listed swallowtail butterfly to boost its resistance to farm-applied insecticides, while Rothamsted Research will edit oak tree genes so they reproduce in months rather than decades, enabling faster adaptation to drought and invasive pathogens.
- Cardiff University mycologist Sarah Christofides is leading a project that injects ash trees with RNA molecules to disrupt the fungus behind ash dieback — a disease expected to kill half of Britain's ash trees — describing the approach as "giving the tree a vaccination."
- Cultivarium, a Boston-based lab partnering with Imperial College and Queen Mary University London, plans to genetically engineer bacteria living on amphibian skin to release proteins that "bind and stop" chytrid fungal infections, which have driven declines in more than 500 amphibian species worldwide.
- Aria chair Matt Clifford was forced to step down this month after taking a job at Anthropic, following broader criticism of the agency for funding controversial geoengineering research and channelling UK taxpayer money to US tech companies and venture capital firms.
- Chris Thomas, founding director of the Leverhulme Centre for Anthropocene Biodiversity at the University of York, said the projects' impact will probably be "modest" and that expecting these interventions to play an important role in preventing biodiversity loss "is probably pretty naive."
- Programme director Yannick Wurm confirmed none of the experimental solutions will be released into the wild during the programme, which runs until 2030, and that all grantees will work in secure labs under an ethical framework built on the IUCN's first global synthetic-biology policy.
Why it matters: Britain is channelling £54m of public money into synthetic biology as a precision tool for conservation, yet the agency's own chair just departed over an Anthropic conflict and a leading biologist says expecting biotech to prevent biodiversity loss is "pretty naive." Because nothing will be released until after 2030, any real-world payoff sits at least a decade out — and the further £24m only flows after measurable laboratory success.
Ask SkimNews
